Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information.
作者信息
Minetto Paola, Guolo Fabio, Clavio Marino, Kunkl Annalisa, Colombo Nicoletta, Carminati Enrico, Fugazza Giuseppina, Matarese Simona, Guardo Daniela, Ballerini Filippo, Di Grazia Carmen, Raiola Anna M, Cagnetta Antonia, Cea Michele, Miglino Maurizio, Lemoli Roberto M, Gobbi Marco
机构信息
Haematology Clinic, Department of Internal Medicine (DiMI), University of Genoa, Policlinico San Martino, IRCCS per l'Oncologia, Genoa, Italy.
Clinical Flow Cytometry Unit, Anatomic Pathology, Policlinico San Martino, IRCCS per l'Oncologia, Genoa, Italy.
出版信息
Br J Haematol. 2019 Feb;184(3):457-460. doi: 10.1111/bjh.15106. Epub 2018 Jan 23.
PMID:29359798
Abstract
摘要
Zotero 插件